Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations Phase II

社区参与的针对服务不足和/或弱势群体的 COVID-19 检测研究第二阶段

基本信息

  • 批准号:
    10544758
  • 负责人:
  • 金额:
    $ 110.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-01-01 至 2024-11-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY The COVID-19 pandemic has caused unprecedented public health and economic consequences globally and in the United States. Long-standing social inequities have been magnified and vulnerable communities have been disproportionately burdened by the pandemic. In Miami-Dade County, Florida, where minority populations experience a high level of social vulnerability, Blacks and Hispanics are overrepresented in COVID-19 related hospitalizations and deaths compared to national rates. Further, Miami-Dade County continues to experience COVID-19 rates well above the state and national levels. Effective vaccines are now available, yet vaccination rates have been persistently lower among U.S. minorities, broadening disparities in COVID-19 outcomes. As such, expanded SARS-CoV-2 testing and vaccine acceptance is critical to mitigating community spread in underserved and vulnerable communities. In this application for Phase II of the RADx-UP project, we will apply the knowledge gained during Phase I to expand community outreach to increase testing and vaccine uptake in minority communities to decrease disparities that contribute to burden of COVID-19 in underserved and vulnerable populations. We propose to continue our RADx-UP community-engaged research by employing new recruitment strategies in conjunction with four community partners to increase reach of testing that include engaging faith leaders and minority health care providers, and placing our mobile testing (and vaccination) unit in church parking areas. We will also conduct a longitudinal study among participants who completed Phase I of the study to assess (a) changes in infection and vaccination status, (b) how the availability of vaccines affects attitudes, beliefs, and behaviors related to testing, (c) changes in SDoH and their impact on COVID-19 testing and vaccine uptake/hesitancy, and (d) the relationship between mental resilience, mental health, and testing and vaccine uptake/hesitancy, and (e) other RADx-UP common data elements. We will also conduct post-infection and post-vaccination studies on antibody production and subsequent infections. For the proposed Phase II application, we have partnered with new community organizations, including Keeping the Faith to Fight COVID-19, an organization of minority health care providers working with Black and Black Hispanic churches, and with the Community Engagement Alliance (CEAL) Against COVID-19 Disparities initiative. We are currently conducting RADx-UP Phase I with established infrastructure and community partnerships to accomplish the aims and enable rapid and measurable impact in access and uptake of SARS- CoV-2 testing by underserved and vulnerable populations. Our community partners have the resources to provide community engagement, public health mitigation, and follow-up care for cases who test positive. Our strategy includes Scientific and Community Advisory Boards; a mobile testing unit; a CLIA-licensed laboratory headed by the PI of this application; data mining and longitudinal approaches for data analyses; and a research team experienced in recruiting and retaining members of the communities targeted in this proposal.
项目摘要 COVID-19大流行在全球范围内造成了前所未有的公共卫生和经济后果, 在美国长期存在的社会不平等现象被放大,脆弱社区 受到大流行病的不成比例的负担。在佛罗里达的迈阿密-戴德县, 经历了高度的社会脆弱性,黑人和西班牙裔在COVID-19相关的 与全国住院率和死亡率相比。此外,迈阿密戴德县继续经历 COVID-19的发病率远高于州和全国水平。现在已经有了有效的疫苗,但疫苗 美国少数族裔的发病率一直较低,扩大了COVID-19结果的差异。作为 这种扩大的SARS-CoV-2检测和疫苗接受对于减缓 服务不足和弱势群体。在RADx-UP项目第二阶段的申请中,我们将申请 在第一阶段获得的知识,以扩大社区外展,以增加测试和疫苗的吸收, 少数族裔社区,以减少导致COVID-19负担的差距, 弱势群体。我们建议继续我们的RADx-UP社区参与的研究, 与四个社区合作伙伴一起制定新的招聘战略,以扩大检测范围,包括 让宗教领袖和少数民族医疗保健提供者参与进来,并将我们的移动的检测(和疫苗接种)单位 在教堂停车场。我们还将在完成第一阶段的参与者中进行纵向研究 评估(a)感染和疫苗接种状况的变化,(B)疫苗的可用性如何 影响与检测相关的态度、信念和行为,(c)SDoH的变化及其对COVID-19的影响 测试和疫苗接种/犹豫,以及(d)心理弹性,心理健康, 测试和疫苗摄取/犹豫,以及(e)其他RADx-UP通用数据元素。我们还将进行 关于抗体产生和随后感染的感染后和接种后研究。为 在第二阶段的申请中,我们与新的社区组织合作,包括保持 信仰抗击COVID-19,一个与黑人和黑人合作的少数民族医疗保健提供者组织 西班牙裔教会,并与社区参与联盟(CEAL)反对COVID-19差异 倡议我们目前正在进行RADx-UP第一阶段,建立了基础设施和社区 建立伙伴关系,以实现目标,并在获得和吸收SARS方面产生迅速和可衡量的影响- CoV-2检测服务不足和弱势群体。我们的社区合作伙伴拥有资源, 提供社区参与、公共卫生缓解和对检测呈阳性的病例的后续护理。我们 战略包括科学和社区咨询委员会;一个移动的测试单位;一个CLIA许可的实验室 由本申请的PI领导;数据挖掘和数据分析的纵向方法;以及 研究团队在招募和留住本提案所针对的社区成员方面经验丰富。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Marianna K Baum其他文献

P23-032-23 Associations Between Antidepressant Use and Fasting Blood Glucose Levels in People Living With and Without HIV
  • DOI:
    10.1016/j.cdnut.2023.100144
  • 发表时间:
    2023-07-01
  • 期刊:
  • 影响因子:
  • 作者:
    Stephanie Gieseken;Quingyun Liu;Marianna K Baum;Haley R Martin;Jupshy Jasmin;Angelique Johnson;Sabrina Sales Martínez;Leslie Seminario;Jose Bastida Rodriguez
  • 通讯作者:
    Jose Bastida Rodriguez

Marianna K Baum的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Marianna K Baum', 18)}}的其他基金

Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations Phase II
社区参与的针对服务不足和/或弱势群体的 COVID-19 检测研究第二阶段
  • 批准号:
    10447463
  • 财政年份:
    2022
  • 资助金额:
    $ 110.58万
  • 项目类别:
Cohort Studies on HIV/AIDS and Substance Abuse in Miami
迈阿密艾滋病毒/艾滋病和药物滥用队列研究
  • 批准号:
    9927614
  • 财政年份:
    2015
  • 资助金额:
    $ 110.58万
  • 项目类别:
Cohort Studies on HIV/AIDS and Substance Abuse in Miami
迈阿密艾滋病毒/艾滋病和药物滥用队列研究
  • 批准号:
    9144756
  • 财政年份:
    2015
  • 资助金额:
    $ 110.58万
  • 项目类别:
Cohort Studies on HIV/AIDS and Substance Abuse in Miami
迈阿密艾滋病毒/艾滋病和药物滥用队列研究
  • 批准号:
    9494556
  • 财政年份:
    2015
  • 资助金额:
    $ 110.58万
  • 项目类别:
Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations
社区参与的针对服务不足和/或弱势群体的 COVID-19 检测研究
  • 批准号:
    10662839
  • 财政年份:
    2015
  • 资助金额:
    $ 110.58万
  • 项目类别:
Alcohol & Antiretrovirals in HIV Infection, Oxidative Stress and Liver Disease
酒精
  • 批准号:
    7590839
  • 财政年份:
    2008
  • 资助金额:
    $ 110.58万
  • 项目类别:
Alcohol & Antiretrovirals in HIV Infection, Oxidative Stress and Liver Disease
酒精
  • 批准号:
    8080463
  • 财政年份:
    2008
  • 资助金额:
    $ 110.58万
  • 项目类别:
Alcohol & Antiretrovirals in HIV Infection, Oxidative Stress and Liver Disease
酒精
  • 批准号:
    8278027
  • 财政年份:
    2008
  • 资助金额:
    $ 110.58万
  • 项目类别:
Alcohol & Antiretrovirals in HIV Infection, Oxidative Stress and Liver Disease
酒精
  • 批准号:
    7857921
  • 财政年份:
    2008
  • 资助金额:
    $ 110.58万
  • 项目类别:
Alcohol & Antiretrovirals in HIV Infection, Oxidative Stress and Liver Disease
酒精
  • 批准号:
    7691806
  • 财政年份:
    2008
  • 资助金额:
    $ 110.58万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 110.58万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 110.58万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 110.58万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 110.58万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 110.58万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 110.58万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 110.58万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 110.58万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 110.58万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 110.58万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了